Yong Tai receives first batch of SZKT's vaccine, paves way to launch phase 3 clinical trial in Malaysia
KUALA LUMPUR (June 10): Property developer Yong Tai Bhd has announced that its subsidiary YTB Healthcare Sdn Bhd (YTBH) today received the first batch of an inactivated Covid-19 vaccine developed by China-based Shenzhen Kangtai Biological Products Co Ltd (SZKT).